cAMP (Cyclic adenosine monophosphate) ELISA Kit

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
cAMP (Cyclic adenosine monophosphate) ELISA Kit
category
ELISA Kits
provider
FineTest
reference
EU2574
tested applications
ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Universal
Assay Data
2 hours
Assay Type
Competitive ELISA, Coated with Antigen
Test Range
0.313-20ng/ml (20ng=60pmol)
Sensitivity
0.188ng/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
Alias
Cathelicidin antimicrobial peptide, 18 kDa cationic antimicrobial protein, CAP-18, hCAP-18, Antibacterial peptide FALL-39, FALL-39 peptide antibiotic, Antibacterial peptide LL-37, Antibacterial peptide KR-20, Antibacterial peptide LL-23, Antibacterial peptide LL-29, Antibacterial peptide KS-30, Antibacterial peptide RK-31, Antibacterial peptide FF-33, CAMP, CAP18, FALL39
Background
Elisa kits for cAMP
Status
RUO

Related Products

EU2574

cAMP (Cyclic adenosine monophosphate) ELISA Kit

Ver Producto
abx015701

Cyclic Adenosine Monophosphate (cAMP) Antibody

Cyclic adenosine monophosphate (cAMP) plays a key role as an intracellular second messenger for transduction events that follow a number of extracellular signals.The G-Protein Coupled Receptors (GPCR) is the largest family of cell surface receptors.They can be activated by different ligands, such as neurotransmitters, hormones, ions, small molecules, peptides, and other physiological signaling molecules.Typically, the binding of the ligands to its receptor resulting in the activation of G-proteins, in return, activates the effector adenylyl cyclase evoking the production of cAMP.The activation of a protein kinase by cAMP results in the phosphorylation of substrate proteins.Currently successful drugs in marketing have been developed to target these receptors.Among the GPCRs, ~367 receptors are potential drug development targets, but only about 20 have been used to generate therapeutically and commercially successful drugs so far.Because the involvement of cAMP can amplify the response of the ligand binding, the second messenger cAMP has been largely employed to monitor the activation of the GPCR to facilitate the therapeutic drug discovery

Ver Producto
abx103136

Cyclic Adenosine Monophosphate (cAMP) Antibody

Polyclonal Antibody to Cyclic Adenosine Monophosphate (cAMP).

Ver Producto